Human Milk Oligosaccharides Market is anticipated to grow considerably in the coming years due to rise in demand for infant nutrition food products. Human milk oligosaccharides are the complex sugars that are produced in the breast milk by mothers in large quantities. They can be assumed as the fibers that cannot be consumed by the newborns. HMO build bifidobacteria that helps in several mechanisms. It prevents the growth of other pathogens in the same environment.
Request a Sample PDF Copy of This Report @ https://www.millioninsights.com/industry-reports/human-milk-oligosaccharides-hmo-market/request-sample
The key driving factors responsible for the growth of Human Milk
Oligosaccharides market :
The drivers of human milk oligosaccharides
market include speedy technological improvements in product line, rise in
application in the infant supplements, growing application in food and
beverages and increasing use in dairy sector. Moreover, change in lifestyle,
rise in health awareness and rising demand for human milk donors are expected
to drive the market growth. However, low availability of raw materials and high
priced chemical and enzymatic synthesis techniques, lack of technical expertise
and significant R&D cost are hampering the market growth.
Nevertheless, leading players
adopting merger& acquisition, affiliations and collaboration strategy and
improvements in supply chain management are a few trends in human milk
oligosaccharides industry. Moreover, future investments are expected to bring
opportunities for the market players.
Human milk oligosaccharides
market is categorized on the basis of type, application and geography. On the
basis of type, the market is divided into LNT &LNnT, sialyllactose and
fucosyllactose. Fucosyllactose segment is predicted to hold larger market share
due to rising use in infant supplements.
Based on application, HMO
industry is divided into food & beverages, health ingredients for human
& animal, infant formulas and food supplements. Infant supplement segment
leads the HMO market due to the increasing number of child malnourishment cases
and growth in mortality.
Geographically, human milk
oligosaccharides industry is segmented as North America, Latin America, Europe,
Asia Pacific and Middle East & Africa. North America followed by Europe are
erected to dominate the market of human milk oligosaccharides due to increasing
number of manufacturers and rise in demand for infant formulas in Italy,
France, Spain and U.K. Europe and Asia Pacific are also projected to lead in
future due to increasing demand for nutritional food products.
The prominent players in human
milk oligosaccharides (HMO) industry include Abbott, Dextra Laboratories,
Inbiose, Jennewein Biotechnologie GmbH, Glycosyn LLC, Glycom A/S, ZuChem, Inc.,
Elicityl SA and Medolac Laboratories.
View Full Table of Contents of This Report @ https://www.millioninsights.com/industry-reports/human-milk-oligosaccharides-hmo-market
No comments:
Post a Comment